Purple Biotech Company Insiders
| PPBT Stock | USD 2.73 0.05 1.80% |
Purple Biotech employs about 9 people. The company is managed by 6 executives with a total tenure of roughly 21 years, averaging almost 3.0 years of service per executive, having 1.5 employees per reported executive. Breaking down Purple Biotech's management performance can provide insight into the firm performance.
Purple Biotech's Workforce Through the Years
Please note that employee historical analysis has become an increasingly important factor for investors assessing the risk associated with Purple Biotech's future performance. Based on our forecasts, it is anticipated that Purple will maintain a workforce of slightly above 19 employees by August 2025.Purple Biotech Management Team Effectiveness
The company has return on total asset (ROA) of (0.1283) % which means that it has lost $0.1283 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.124) %, meaning that it created substantial loss on money invested by shareholders. Purple Biotech's management efficiency ratios could be used to measure how well Purple Biotech manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.83 in 2025. Return On Capital Employed is likely to drop to -0.35 in 2025. Change To Liabilities is likely to gain to about 964.8 K in 2025, whereas Total Current Liabilities is likely to drop slightly above 3.8 M in 2025.Common Stock Shares Outstanding is likely to gain to about 2.7 M in 2025, whereas Net Loss is likely to drop (20.5 M) in 2025.
Purple Biotech Workforce Comparison
Purple Biotech is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 115. Purple Biotech holds roughly 9.0 in number of employees claiming about 8% of equities under Health Care industry.
Purple Biotech Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Purple Biotech Price Series Summation is a cross summation of Purple Biotech price series and its benchmark/peer.
Purple Biotech Notable Stakeholders
A Purple Biotech stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Purple Biotech often face trade-offs trying to please all of them. Purple Biotech's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Purple Biotech's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| MA CPA | Chief Officer | Profile | |
| Fabien Sebille | Chief Officer | Profile | |
| Michael Schickler | Head Affairs | Profile | |
| LLM BSc | Vice Operations | Profile | |
| Ido Morpurgo | VP Operations | Profile | |
| Nir Livneh | VP Affairs | Profile |
About Purple Biotech Management Performance
The success or failure of an entity such as Purple Biotech often depends on how effective the management is. Purple Biotech management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Purple management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Purple management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.79) | (0.83) | |
| Return On Capital Employed | (0.33) | (0.35) | |
| Return On Assets | (0.20) | (0.21) | |
| Return On Equity | (0.22) | (0.23) |
Please note, the imprecision that can be found in Purple Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Purple Biotech. Check Purple Biotech's Beneish M Score to see the likelihood of Purple Biotech's management manipulating its earnings.
Purple Biotech Workforce Analysis
Traditionally, organizations such as Purple Biotech use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Purple Biotech within its industry.Purple Biotech Manpower Efficiency
Return on Purple Biotech Manpower
| Revenue Per Employee | 0.0 | |
| Revenue Per Executive | 0.0 | |
| Net Loss Per Employee | 808.8K | |
| Net Loss Per Executive | 1.2M | |
| Working Capital Per Employee | 546.8K | |
| Working Capital Per Executive | 820.2K |
Additional Tools for Purple Stock Analysis
When running Purple Biotech's price analysis, check to measure Purple Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Purple Biotech is operating at the current time. Most of Purple Biotech's value examination focuses on studying past and present price action to predict the probability of Purple Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Purple Biotech's price. Additionally, you may evaluate how the addition of Purple Biotech to your portfolios can decrease your overall portfolio volatility.